Therapeutic Protein Pipeline Database: 1-Year Subscription
Product description
Subscription to La Merie’s proprietary Therapeutic Protein Pipeline Database provides online access to more than 1,700 project entries for therapeutic proteins on the market and in research & development. Each project is specified for its Target or Mechanism of Action, Therapeutic Area and R&D Phase. Use of the R&D database of therapeutic proteins is intuitive. Data sets of interest can be printed and exported. Projects are being updated continuously by passive and active searches. Information from press releases is entered on a daily basis. Active searches for targets, indications, company pipelines, scientific congresses, corporate releases, publications and in other sources is conducted on a rotating, regular basis. The R&D history of each project with online references of information sources can be viewed and printed. Sales figures of major products are provided. The projects can be segmented into Territories, Therapeutic Areas and R&D Phases. An advanced search function allows to combine search parameters. A scroll down menu for predefined targets conveniently selects projects of interest. By clicking on column heads of the project list, projects can be arranged in ascending or descending alphabetical or numerical order, e.g. for phase, product category or company name. Sample screenshots illustrate the database.
Purchase of the subscription provides a 1-year online access to the data of the Therapeutic Protein Pipeline Database. Credentials to access the database will be sent by e-mail within 24 hours after purchase.
Benefits from the Therapeutic Protein Pipeline Database:
Subscription to La Merie’s proprietary Therapeutic Protein Pipeline Database provides online access to more than 1,700 project entries for therapeutic proteins on the market and in research & development. Each project is specified for its Target or Mechanism of Action, Therapeutic Area and R&D Phase. Use of the R&D database of therapeutic proteins is intuitive. Data sets of interest can be printed and exported. Projects are being updated continuously by passive and active searches. Information from press releases is entered on a daily basis. Active searches for targets, indications, company pipelines, scientific congresses, corporate releases, publications and in other sources is conducted on a rotating, regular basis. The R&D history of each project with online references of information sources can be viewed and printed. Sales figures of major products are provided. The projects can be segmented into Territories, Therapeutic Areas and R&D Phases. An advanced search function allows to combine search parameters. A scroll down menu for predefined targets conveniently selects projects of interest. By clicking on column heads of the project list, projects can be arranged in ascending or descending alphabetical or numerical order, e.g. for phase, product category or company name. Sample screenshots illustrate the database.
Purchase of the subscription provides a 1-year online access to the data of the Therapeutic Protein Pipeline Database. Credentials to access the database will be sent by e-mail within 24 hours after purchase.
Benefits from the Therapeutic Protein Pipeline Database:
- New database with no historical burden
- Intuitive use
- Designed for structured searches
- Focused on targets, therapeutic areas and R&D phases
- Ideal for competitor analysis (companies, targets, product categories)
- Cost-effective and rapid solution for benchmarking
- Identification of licensing candidates
- Drug Codes
- Target / Mechanism of Action
- Class of Compound
- Product Category
- Company
- Territory
- Therapeutic Area
- Indication
- R&D Phase
- Cardiovascular & blood
- Dermatology
- Gastrointestinal
- Genitourinary, renal & gynecology
- Infectious & toxicology
- Metabolism & endocrine
- Neurology & psychiatry
- Oncology
- Ophthalmology & otorhinolaryngology
- Orthopedics, dental, anesthesia & surgery
- Pulmonary & respiratory
- Rheumatoid & autoimmune
- Erythropoietin (EPO) & Erythropoiesis Stimulating Agents (ESA)
- G-CSF & GM-CSF
- Thrombopoietin & Thrombopoiesis Stimulating Agents
- Interferon
- Insulin
- Coagulation Factor
- Human Growth Hormone (hGH)
- FSH etc
- Thrombolytics & Fibrinolytics
- Enzyme Replacement & Enhancement Therapies
- Growth Factors
